WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD. founded in 1939 has a history of 63 years. It turned into a joint-stock co***ny in 1994.WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD. consists of 3-shared subsidiary co***nies, 10 workshops and one R & D Center. It covers an area of 220,000 square meters. Its registered capital is RMB 83.26912 million, equal to about USD 10 million. Its annual sales volume is over USD 40 million and active pharmaceutical ingredients worth of USD 12 million are exported.
The main business of WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD. is the production and distribution of pharmaceutical ingredients, intermediates and preparations. It has an annual production capacity of more than 4000 tons in pharmaceutical ingredients, 4000 million units in solid pharmaceutical preparations (Tablets and Capsules), 200 million units in liquid pharmaceutical preparations (Injection, Infusion and Eye Drops).
There are 7 sorts of pharmaceutical ingredients and intermediates in WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD., including antimicrobial drugs, antibechics, ophthalmic preparations, anticancer drugs, cardiovascular drugs, antipyretics and analgesics. The main products consist of Analgin, Chloramphenicol, Metronidazole, Enoxacin, Enoxacin Gluconate Pirenoxin Sodium, Adrenline, Noradrenaline Bitartrate, Xylometazoline Hydrochloride, Carbazochrome, Tiopronin, aminphyrine and so on.
The pharmaceutical preparations of WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD. are Enoxacin Tablets, Capsules, Infusion and Eye Drops, Pirenoxine Sodium Eye Drops, Xylometazoline Hydrochloride Nasal Drops And Aerosol, Tiopronin Tablets, and over 100 kinds of other products of Injection, Infusion, Tablets, Capsules and Eye Drops.
|
Home
